Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis

Authors :: Ruiyun Xu
Huiling Zhang
Yuesi Zhong
Nan Lin
Zheng Zhou
Mingxing Xu
Source :: World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-9 (2019), World Journal of Surgical Oncology
Publication Year :: 2019
Publisher :: Springer Science and Business Media LLC, 2019.
Abstract: Background The effect of antiviral therapy (AVT) on clinical outcomes in patients with hepatocellular carcinoma (HCC) who are seronegative for hepatitis B virus (HBV), defined as HBV DNA

Subjects :: Male
HBsAg
Negative HBV DNA
Survival
Hepatocellular carcinoma
medicine.medical_treatment
Antiviral therapy
medicine.disease_cause
Gastroenterology
0302 clinical medicine
Risk Factors
Surgical oncology
Postoperative Period
Liver Neoplasms
Middle Aged
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Survival Rate
Liver
Oncology
030220 oncology & carcinogenesis
Cohort
Female
030211 gastroenterology & hepatology
Hepatitis B virus
medicine.medical_specialty
Carcinoma, Hepatocellular
lcsh:Surgery
Antiviral Agents
lcsh:RC254-282
Disease-Free Survival
03 medical and health sciences
Antigen
Internal medicine
medicine
Hepatectomy
Humans
Propensity Score
Retrospective Studies
business.industry
Research
lcsh:RD1-811
medicine.disease
digestive system diseases
DNA, Viral
Propensity score matching
Virus Activation
Surgery
business

Tools